Cross-country collaboration on ALS research

Issue: BCMJ, vol. 59, No. 1, January February 2017, Page 57 News

The ALS Society of Canada will spearhead Canada’s participation in the international research partnership, Project MinE. The project’s ultimate goal is to identify genes that are associated with amyotrophic lateral sclerosis (ALS). The function of these genes may lead to disease pathways for which treatment can be developed. Project MinE will map the full DNA profiles of 15 000 people with ALS and 7500 control subjects to establish a global resource of human data that will enable scientists worldwide to better target the disease by understanding the genetic signature that leads someone to develop it. By accumulating such a large amount of data that no one country could achieve alone, it is expected that Project MinE could identify new genetic causes of the disease and potentially accelerate researchers’ abilities to advance treatment possibilities that could slow down or stop ALS. Canada’s goal is to contribute up to 1000 DNA profiles to the international effort.

The ALS Society of Canada is directing an initial $150 000 to Project MinE and is seeking funding from the federal government to support Canada’s ongoing participation in the initiative. Federal funding for Project MinE would allow for the stored DNA profiles of people with ALS to be contributed to the project, and it would enable all Canadians living with ALS to contribute a DNA sample to Project MinE if they so choose.

Research expertise for Canada’s effort is being provided by four of the country’s leading ALS geneticists in Vancouver (Dr Ian Mackenzie), Toronto (Dr Ekaterina Rogaeva), Montreal (Dr Guy Rouleau), and Quebec City (Dr Nicolas Dupre).

. Cross-country collaboration on ALS research. BCMJ, Vol. 59, No. 1, January, February, 2017, Page(s) 57 - News.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply